Volumen 3, Ausgabe 2 (2013)
Klinischer Trail-Prospekt
Can mouse models of cancer reliably improve clinical trial outcome?
Grit S Herter-Sprie & Kwok-Kin Wong
Rückblick: Ergebnisse klinischer Studien
Daclatasvir, an efficient inhibitor of the hepatitis C virus replication complex protein NS5A: review of virologic data, treatment ationale and clinical trials.
Stanislas Pol
Forschungsupdate
Helping each other regulate clinical trials: a network of vaccine regulators from developing countries
Sergio A Nishioka, James Southern, Rolando Dominguez, Nora Dellepiane
Rückblick: Ergebnisse klinischer Studien
Future perspectives on the pharmacological management of depression
Sarah Yates, Eleanor Smith, Hamid A Alhaj, R Hamish McAllister-Williams
Klinischer Trail-Prospekt
What should be the primary end point in irritable bowel syndrome?
Allen W Mangel
Rückblick: Ergebnisse klinischer Studien
New developments in the diagnosis and treatment of axial spondyloarthritis
Pedro Machado, Robert Landewe, Desiree van der Heijde
Rückblick: Ergebnisse klinischer Studien
Mesenchymal stem cells in neurological diseases
Ibrahim Kassis, Panayiota Petrou, Adi Vaknin-Dembinsky, Dimitrios Karussis
